Literature DB >> 737439

Response to penicillamine of lead concentrations in CSF and blood in patients with motor neurone disease.

A O House, R J Abbott, D L Davidson, I T Ferguson, J A Lenman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 737439      PMCID: PMC1608994          DOI: 10.1136/bmj.2.6153.1684

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Amyotrophic lateral sclerosis and metallic toxins.

Authors:  R D Currier; A F Haerer
Journal:  Arch Environ Health       Date:  1968-11

2.  Motor neurone disease and exposure to lead.

Authors:  A M Campbell; E R Williams; D Barltrop
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-12       Impact factor: 10.154

3.  Improvement of spinal amyotrophy by penicillamine therapy.

Authors:  A Jusić; M Sostarko
Journal:  Lancet       Date:  1977-11-12       Impact factor: 79.321

4.  Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry.

Authors:  S Conradi; L O Ronnevi; O Vesterberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-05       Impact factor: 10.154

5.  Abnormal tissue distribution of lead in amyotrophic lateral sclerosis.

Authors:  S Conradi; L O Ronnevi; O Vesterberg
Journal:  J Neurol Sci       Date:  1976-10       Impact factor: 3.181

  5 in total
  3 in total

1.  Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases.

Authors:  E Kapaki; J Segditsa; C Zournas; D Xenos; C Papageorgiou
Journal:  Experientia       Date:  1989-12-01

2.  High accuracy (stable isotope dilution) measurements of lead in serum and cerebrospinal fluid.

Authors:  W I Manton; J D Cook
Journal:  Br J Ind Med       Date:  1984-08

Review 3.  Understanding the human health effects of chemical mixtures.

Authors:  David O Carpenter; Kathleen Arcaro; David C Spink
Journal:  Environ Health Perspect       Date:  2002-02       Impact factor: 9.031

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.